MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway

MicroRNA‐200a suppresses prostate cancer progression through BRD4/AR signaling pathway

Abstract Prostate cancer is still considered a significant health care challenge worldwide due in part to the distinct transformation of androgen‐dependent prostate cancer (ADPC) into treatment‐refractory castration‐resistant prostate cancer (CRPC). Consequently, there is an urgent need to explore n...

Full description

Bibliographic Details
Main Authors: Han Guan, Zonghao You, Can Wang, Fang Fang, Rui Peng, Likai Mao, Bin Xu, Ming Chen
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Cancer Medicine
Subjects:
androgen receptor
BRD4
miRNA
prostate cancer
signaling pathway
Online Access:https://doi.org/10.1002/cam4.2029

Internet

https://doi.org/10.1002/cam4.2029

Similar Items